A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections
Inge C. Gyssens, Matthew Dryden, Peter Kujath, Dilip Nathwani, Nicolaas Schaper, Barbara Hampel, Peter Reimnitz, Jeff Alder, Pierre Arvis
48
Link öffnet neuen Tab
Zitate (Scopus)